TYMS and cancer: The most significantly upregulated microRNA in the simvastatin-treated MDA-MB 231 cells from our study was microRNA-612 (Table 3), which is known to reduce stemness and to relieve drug resistance to cisplatin and 5-fluorouracil, possibly by targeting TYMS in cancer cells (35).